Indomo
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $22M
Investors
- 3
About Indomo
Indomo specializes in innovative therapeutics aimed at improving access to healthcare. The company was formed with a focus on developing the ClearPen™ System, which allows patients to self-administer acne treatment.Indomo specializes in innovative device-enabled therapeutics aimed at improving access to quality healthcare. The company's primary offering is the ClearPen™ System, which combines their drug candidate, DT-001, with a novel intradermal self-injection device. This system empowers patients to administer intralesional triamcinolone acetonide injections for treating inflammatory acne lesions at home, addressing a critical gap in dermatological care. Indomo's products are currently in development and target patients with moderate to severe acne lesions, particularly in regions where access to in-office treatments is limited.Indomo's revenue model focuses on the commercialization of the ClearPen™ System. The company envisions a direct-to-consumer transaction structure that enables patients to purchase the device and the accompanying drug on an as-needed basis. This model allows for flexibility in self-administration outside clinical settings, enhancing adherence. Transaction types may include one-time purchases or subscription plans for ongoing supplies of the device and drug. While specific pricing details are not disclosed, the model is designed to attract a diverse customer base, including individual patients seeking acne treatment. Additionally, the company plans to explore expansion into international markets where access to dermatological services is limited, with specific timelines yet to be defined. This strategic investment aims to bolster Indomo's capabilities in addressing the needs of patients seeking convenient and effective acne treatments.
Who invested in Indomo
3 investors across 1 round
See all investors in Indomo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 29, 2025
Amount
$22M
Investors
Questions about Indomo
Who invested in Indomo?
Indomo has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Indomo raised?
Indomo has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Indomo last raise money?
Indomo's most recent round on record is a Series B, in Oct 2025.
What does Indomo do?
Indomo specializes in innovative therapeutics aimed at improving access to healthcare.
Where is Indomo headquartered?
Indomo is headquartered in San Francisco, US.
Which VCs invest in companies like Indomo?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Indomo's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Indomo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.